We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
-6.98%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.64B
AUM Growth
-$127M
(-7.2%)
Cap. Flow
+$15.3M
Cap. Flow
% of AUM
0.94%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
245
New
6
Increased
57
Reduced
127
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$13.8M |
| 2 |
Teradyne
TER
|
+$6.29M |
| 3 |
Medtronic
MDT
|
+$2.61M |
| 4 |
Carrier Global
CARR
|
+$2.1M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$16.6M |
| 2 |
NVIDIA
NVDA
|
+$3.38M |
| 3 |
Teladoc Health
TDOC
|
+$2.72M |
| 4 |
Apple
AAPL
|
+$1.75M |
| 5 |
3M
MMM
|
+$952K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.14% |
| 2 | Technology | 23.75% |
| 3 | Industrials | 13.49% |
| 4 | Communication Services | 11.24% |
| 5 | Consumer Discretionary | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Ericsson
ERIC
$33.4B
| $105K | 0.01% |
11,504
-73
| -0.6% | -$760 |
|
227
Butterfly Network
BFLY
$2.52B
| $102K | 0.01% |
21,375
-3,100
| -13% | -$17K |
|
|
DM
228
DELISTED
Desktop Metal, Inc.
DM
| $92K | 0.01% |
1,949
-2,779
| -59% | -$118K |
|
229
Senseonics Holdings Inc
SENS
$419M
| $34K | ﹤0.01% |
865
| – | – |
|
230
Arthur J. Gallagher & Co
AJG
$65.5B
| – | – |
-1,254
| Closed | -$213K |
|
231
American Water Works
AWK
$26.8B
| – | – |
-1,275
| Closed | -$241K |
|
232
Charles River Laboratories
CRL
$13.6B
| – | – |
-700
| Closed | -$264K |
|
233
Equity Residential
EQR
$24.2B
| – | – |
-2,210
| Closed | -$200K |
|
234
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
| – | – |
-4,810
| Closed | -$382K |
|
235
Floor & Decor
FND
$6.32B
| – | – |
-1,700
| Closed | -$221K |
|
236
Gilead Sciences
GILD
$168B
| – | – |
-3,095
| Closed | -$225K |
|
237
GSK
GSK
$101B
| – | – |
-5,424
| Closed | -$299K |
|
238
Netflix
NFLX
$309B
| – | – |
-6,210
| Closed | -$374K |
|
239
RPM International
RPM
$14.7B
| – | – |
-2,400
| Closed | -$242K |
|
240
Shopify
SHOP
$194B
| – | – |
-1,970
| Closed | -$271K |
|
241
Stanley Black & Decker
SWK
$15.5B
| – | – |
-1,824
| Closed | -$344K |
|
242
AT&T
T
$166B
| – | – |
-12,121
| Closed | -$225K |
|
243
TE Connectivity
TEL
$62B
| – | – |
-1,491
| Closed | -$241K |
|
244
West Pharmaceutical
WST
$24.8B
| – | – |
-465
| Closed | -$218K |
|
|
XLNX
245
DELISTED
Xilinx Inc
XLNX
| – | – |
-78,495
| Closed | -$16.6M |
|
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
NIM
C
Reynders McVeigh Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Reynders McVeigh Capital Management held 245 positions worth $1.64B, down 7.2% from $1.76B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Reynders McVeigh Capital Management's Q1 2022 filing shows 6 new, 57 increased, 127 reduced and 16 closed positions. Its largest new stake was Advanced Micro Devices: 115,815 shares worth $12.7M. The largest sale was Xilinx Inc, an estimated $16.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.
- Reynders McVeigh Capital Management's largest Q1 2022 buy was Advanced Micro Devices: 115,815 shares worth $12.7M.
- Reynders McVeigh Capital Management added most to Medtronic in Q1 2022, an estimated $2.61M increase.
- Reynders McVeigh Capital Management's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $3.38M.
- Reynders McVeigh Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $16.6M.
- Reynders McVeigh Capital Management's ten largest holdings make up 37% of its $1.64B portfolio in Q1 2022.
- Reynders McVeigh Capital Management opened 6 new positions and closed 16 in Q1 2022.
- Reynders McVeigh Capital Management's portfolio value fell 7.2% quarter-over-quarter to $1.64B.
Based on Reynders McVeigh Capital Management's 13F filing for Q1 2022, filed 11 May 2022.